Dr. Charilaou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1025 Morehead Medical Dr
Ste 300
Charlotte, NC 28204Phone+1 704-355-4593
Summary
- Dr. Paris Charilaou is a gastroenterologist and Inflammatory Bowel Disease specialist in Charlotte, NC. He received his medical degree from Charles University in Prague, 1st Faculty of Medicine. He focuses on inflammatory bowel disease, with research interest in precision medicine with predictive models using ML in IBD.
Education & Training
- New York Presbyterian HospitalFellowship, Inflammatory Bowel Disease, 2021 - 2022
- Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolResidency, Gastroenterology, 2015 - 2022
- Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolFellowship, Gastroenterology, 2018 - 2021
- Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolChief Residency, Internal Medicine, 2017 - 2018
- Charles University in Prague Faculty of MedicineClass of 2013
Certifications & Licensure
- NC State Medical License 2021 - 2025
- NY State Medical License 2020 - 2022
- NJ State Medical License 2018 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Poster of Distinction DDW - AGA, 2022
- Fellows In-Training Award ACG, 2017
Publications & Presentations
PubMed
- Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Survei...Sonmoon Mohapatra, Sarah S Al Ghamdi, Paris Charilaou, Chawin Lopimpisuth, Amit Das
Gastrointestinal Endoscopy. 2024-11-01 - Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy.Rochelle Wong, Paris Charilaou, Amy Hemperly, Lihui Qin, Yushan Pan
Crohn's & Colitis 360. 2024-10-01 - 6 citationsIncreased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease.Robert Battat, Ellen J Scherl, Dana Lukin, Paris Charilaou, Prerna Mahtani
Journal of Crohn's & Colitis. 2023-05-03
Journal Articles
- An Unusual Cause of Rectal Bleeding in a 34-Year-Old MaleMaanit Kohli, Paris Charilaou, Devendra Enjamuri, Marnie Rosenthal, Nature
Authored Content
- Acute kidney injury and inpatient mortalityOctober 2018
Press Mentions
- Featured S & SApril 6th, 2020
Research History
- Yale Aortic Institute2013 - 2015
Professional Memberships
- Fellow
- Member
- Member
- Member
- American Society of Gastrointestinal EndoscopyMember
- Crohn's and Colitis FoundationMember
Other Languages
- Greek
External Links
- LinkedInhttps://www.linkedin.com/in/paris-charilaou-a3721382/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: